Zimmer to Buy Abbott Spine for $360 Million

Zimmer Holdings has announced its plans to buy Abbott Laboratories' spine division. The $360-million deal should be completed by this year's fourth quarter. Zimmer's spine business reached $197 million in sales last year, only five percent of its total sales. Abbott Spine hit $109 million in 2007, which is a very small portion of its total drug and device sales revenue of $25.9 billion.